直接口服抗凝药与抗心律失常药的安全性与相互作用
本文综述直接口服抗凝药(DOAC)与抗心律失常药(AAD)联用的安全性与相互作用,涉及达比加群、利伐沙班、阿哌沙班和艾多沙班。相互作用主要经细胞色素P450系统和P-糖蛋白转运系统介导,部分组合建议减少DOAC剂量,某些情况存在禁忌。肾功能和肝功能损害在该背景下起重要作用,但相关研究尚不充分。
要点
- DOAC与AAD的相互作用经CYP450和P-糖蛋白系统介导。
- 部分DOAC与AAD组合建议减少DOAC剂量,某些情况存在禁忌。
- 肾功能和肝功能损害影响DOAC与AAD联用的安全性。
核心结论
- DOAC与AAD联用仍存在相互作用,部分组合需减少DOAC剂量,某些情况存在禁忌。
研究设计与样本
- 本文为综述,汇总关于AAD与DOAC联用安全性及相互作用的文献。
主要发现
- DOAC与AAD的相互作用由细胞色素P450系统和P-糖蛋白转运系统介导。
- 部分DOAC与AAD组合建议减少DOAC剂量,某些情况存在禁忌。
- 肾功能和肝功能损害在DOAC与AAD联用背景下起重要作用。
局限性
- 肾功能和肝功能损害对DOAC与AAD联用影响的研究尚不充分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Direct oral anticoagulants (DOACs) are novel direct-acting medications that are selective for either thrombin or activated factor X. Due to their obvious benefits for patients (fewer interactions, broader therapeutic window, etc.), they are increasingly used as an alternative to warfarin, phenprocoumon, or acenocoumarol. One of the major indications for use of DOACs is stroke prevention in patients with atrial fibrillation (AF). However, interactions still exist, especially in combination with antiarrhythmic drugs (AADs), which are frequently given to AF patients for rhythm or rate control. These interactions are due to the cytochrome P450 system and the P-glycoprotein (permeability glycoprotein or multidrug resistance protein) transport system. For some combinations, dose reduction of the DOAC is recommended and in some cases contraindications exist. In addition, impairment in renal and hepatic function plays an important role in this context. However, compared with pure interactions where data are quite convincing, the latter topic has been studied only rudimentarily. This review summarizes the literature on the safety and interactions of AADs when used with DOACs [dabigatran (a direct inhibitor of factor IIa) and rivaroxaban, apixaban and edoxaban (direct inhibitors of factor Xa)] and the impact of renal and hepatic impairment.
引用
- Celikyurt I, Meier CR, Kühne M, et al. Safety and Interactions of Direct Oral Anticoagulants with Antiarrhythmic Drugs. Drug Saf. 2017. PMID: 28689334. doi:10.1007/s40264-017-0567-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。